MEI Pharma Rebrands as Litecoin Strategy: Stock Soars

MEI Pharma, a publicly traded company listed on the U.S. stock market, has officially rebranded to Litecoin Strategy. The change is accompanied by a new Nasdaq ticker symbol, LITS. Following this announcement, the company’s share price saw an impressive intraday gain of 10.61%, significantly boosting its market capitalization to approximately $101 million.